Over the past 12 months, 4 insiders at Arcellx, Inc. filed 22 open-market SEC Form 4 transactions on ACLX: 0 purchases worth $0 and 22 sales worth $18.6M. Insiders have been net sellers over this period. The most recent filing was on Feb 27, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 26 | Rami ElghandourSEE REMARKS | SELL | 89.9K | $113.92 | $10.2M |
| Feb 25, 26 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 11.2K | $113.82 | $1.3M |
| Feb 19, 26 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 5.4K | $69.38 | $371K |
| Feb 17, 26 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 7.1K | $70.01 | $494K |
| Jan 20, 26 | David Charles LubnerDirector | SELL | 6.0K | $75.00 | $450K |
| Jan 14, 26 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 5.9K | $68.51 | $403K |
| Jan 13, 26 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 7.4K | $65.51 | $487K |
| Jan 12, 26 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 6.1K | $64.15 | $393K |
| Nov 17, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 340 | $90.00 | $31K |
| Oct 15, 25 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 5.4K | $91.04 | $488K |
| Oct 6, 25 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 1.1K | $86.22 | $92K |
| Oct 3, 25 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 4.9K | $86.00 | $420K |
| Sep 30, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 14.2K | $82.20 | $1.2M |
| Sep 29, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 73 | $80.16 | $6K |
| Sep 26, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 12.4K | $80.12 | $993K |
| Sep 19, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 300 | $80.00 | $24K |
| Sep 18, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 3.3K | $80.01 | $267K |
| Jun 10, 25 | Kavita PatelDirector | SELL | 1.5K | $67.36 | $101K |
| May 27, 25 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 8.4K | $64.38 | $544K |
| May 20, 25 | Kavita PatelDirector | SELL | 1.5K | $58.43 | $88K |
| Apr 29, 25 | Kavita PatelDirector | SELL | 1.5K | $64.20 | $96K |
| Apr 8, 25 | Kavita PatelDirector | SELL | 1.5K | $57.50 | $86K |
| Mar 18, 25 | Kavita PatelDirector | SELL | 1.5K | $71.64 | $107K |
| Feb 26, 25 | Rami ElghandourSEE REMARKS | SELL | 21.1K | $62.69 | $1.3M |
| Feb 25, 25 | Kavita PatelDirector | SELL | 1.5K | $63.16 | $95K |
| Feb 24, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 5.6K | $64.88 | $358K |
| Feb 4, 25 | Kavita PatelDirector | SELL | 1.5K | $64.57 | $97K |
| Jan 14, 25 | Kavita PatelDirector | SELL | 800 | $67.32 | $52K |
| Jan 8, 25 | Rami ElghandourSEE REMARKS | SELL | 13.8K | $73.69 | $1.0M |
| Jan 8, 25 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 4.0K | $73.69 | $295K |
| Jan 8, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 3.6K | $73.69 | $262K |
| Jan 7, 25 | Rami ElghandourSEE REMARKS | SELL | 16.5K | $75.53 | $1.2M |
| Jan 7, 25 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 4.8K | $77.06 | $360K |
| Jan 7, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 4.2K | $75.53 | $319K |
| Jan 6, 25 | Rami ElghandourSEE REMARKS | SELL | 15.1K | $77.17 | $1.2M |
| Jan 6, 25 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 5.6K | $77.17 | $434K |
| Jan 6, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 3.1K | $77.17 | $236K |
| Jan 3, 25 | Rami ElghandourSEE REMARKS | SELL | 15.1K | $79.55 | $1.2M |
| Jan 3, 25 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 5.6K | $79.55 | $447K |
| Jan 3, 25 | Christopher HeeryCHIEF MEDICAL OFFICER | SELL | 3.3K | $79.55 | $263K |
| Dec 24, 24 | Kavita PatelDirector | SELL | 1.4K | $77.61 | $108K |
| Dec 3, 24 | Kavita PatelDirector | SELL | 400 | $91.91 | $36K |
| Nov 15, 24 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 1.1K | $95.00 | $93K |
| Nov 12, 24 | Kavita PatelDirector | SELL | 1.5K | $106.33 | $159K |
| Nov 11, 24 | Kavita PatelDirector | SELL | 12.2K | $106.91 | $1.3M |
| Nov 8, 24 | Michelle GilsonCHIEF FINANCIAL OFFICER | SELL | 9.7K | $102.33 | $973K |
| Nov 8, 24 | Kavita PatelDirector | SELL | 25.8K | $105.46 | $2.7M |
| Nov 7, 24 | Kavita PatelDirector | SELL | 8.5K | $99.30 | $842K |
| Oct 22, 24 | Kavita PatelDirector | SELL | 1.5K | $89.69 | $135K |
| Oct 1, 24 | Kavita PatelDirector | SELL | 1.5K | $82.24 | $123K |
Over the past 12 months, insiders at Arcellx, Inc. filed 0 open-market purchases worth $0 and 22 sales worth $18.6M on ACLX, which makes them net sellers over the period. The most recent Form 4 was filed on Feb 27, 26.
4 different insiders at Arcellx, Inc. filed open-market SEC Form 4 transactions on ACLX over the last 12 months.
InsiderTape plots every ACLX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Arcellx, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →